(68)Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients

We evaluated the clinical utility of (68)Ga-PSMA-11 PET/CT for staging and risk stratification of treatment-naïve prostate cancer (PCa) and metastatic castrate-resistant prostate cancer (mCRPC). Twenty-two consecutive patients with treatment-naïve PCa and 18 with mCRPC were enrolled. (68)Ga-PSMA-11...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Shiming, Shao, Guoqiang, Cui, Can, Li, Tian-Nv, Huang, Yue, Yao, Xiaochen, Fan, Qiu, Chen, Zejun, Du, Jin, Jia, Ruipeng, Sun, Hongbin, Hua, Zichun, Tang, Jun, Wang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355341/
https://www.ncbi.nlm.nih.gov/pubmed/28103574
http://dx.doi.org/10.18632/oncotarget.14691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355341/
https://www.ncbi.nlm.nih.gov/pubmed/28103574
http://dx.doi.org/10.18632/oncotarget.14691

Ejemplares similares